Result of Retail Offer
Cellbxhealth plc has announced the successful closure of its Retail Offer, raising approximately £0.96 million through the issuance of 95,869,449 Retail Offer Shares at 1.0 pence each, subject to the passing of resolutions at a General Meeting on December 15, 2025. In aggregate, the company has conditionally raised £7.8 million at the Issue Price, with a total of 775,869,449 New Ordinary Shares to be issued, resulting in an enlarged share capital of 1,098,511,117 New Ordinary Shares upon admission, expected on December 16 and December 18, 2025.
Select text to share a quote on X · sign in to keep highlights & notes in your CLBX notes
The Board of CELLBXHEALTH plc (the "Company") (AIM: CLBX), a leader in circulating tumour cell (CTC) intelligence, is pleased to announce that the Retail Offer launched on 25 November 2025 has now closed, raising gross proceeds of approximately £0.96 million. Subject to the Retail Offer becoming unconditional, a total of 95,869,449 Retail Offer Shares will be issued at a price of 1.0 pence each.
As set out in the circular published on 25 November 2025, the issue of the Retail Offer Shares is conditional upon the Resolutions being duly passed without amendment at the General Meeting to be held on 15 December 2025.
Following the close of the Retail Offer, the Company has conditionally raised, in aggregate, gross proceeds of approximately £7.8 million at the Issue Price via the Fundraising. Subject to the passing of the Resolutions at the General Meeting, the Company will issue and allot a total of 775,869,449 New Ordinary Shares. The issued share capital of the Company following Admission (including the New Ordinary Shares) (the "Enlarged Share Capital") will be a total of 1,098,511,117 New Ordinary Shares.
Subject to the passing of the Resolutions, First Admission of 9,090,000 First Tranche Fundraising Shares is expected to occur at 8.00 a.m. on or around 16 December 2025. Second Admission will be in respect of 766,779,449 Second Tranche Placing Shares, the Subscription Shares and the Retail Offer Shares and is expected to occur at 8.00 a.m. on 18 December 2025 (or, in each case, such later time and/or date as the Company and Cavendish may agree (being no later than 8.00 a.m. on 16 January 2026)).
A separate announcement will be made following the General Meeting of the results of the General Meeting and the total voting rights following Admission.
Cavendish Capital Markets Limited ("Cavendish") acted as Nominated Adviser, Broker and Bookrunner in connection with the Fundraising.
Unless otherwise defined, all capitalised terms used but not defined in this announcement shall have the meaning given to them in the announcement of the Fundraising made by the Company on 24 November 2025.
The Company's LEI is 213800BY11K6W3NMS374
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.